630 West Germantown Pike
Plymouth Meeting, PA 19462
484 539 9800
|Mr. Jeffrey S. Aronin||Founder & Exec. Chairman||85k||N/A||1968|
|Dr. Jeffrey M. Dayno M.D.||Interim CEO, Exec. VP & Chief Medical Officer||702,74k||1,48M||1957|
|Mr. Sandip S. Kapadia C.P.A., M.B.A.||Exec. VP & CFO||717,03k||N/A||1970|
|Mr. Jeffrey Dierks M.B.A.||Exec. VP & Chief Commercial Officer||613,88k||1,23M||1972|
|Mr. Andrew Serafin J.D., M.B.A.||Exec. VP & Chief Strategy Officer||570,92k||N/A||1975|
|Mr. David Bradshaw||Head of Technical Operations||N/A||N/A||N/A|
|Ms. Sharon Goldbach||Head of Facilities Operations & Exec. Admin.||N/A||N/A||N/A|
|Luis Sanay||Head of Investor Relations||N/A||N/A||N/A|
|Mr. Christian Ulrich||Gen. Counsel||N/A||N/A||N/A|
|Ms. Tricia Glover||Chief Compliance Officer||N/A||N/A||N/A|
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
Harmony Biosciences Holdings, Inc.s ISS Governance QualityScore, Stand 30. März 2023, lautet 9. Die grundlegenden Scores sind Audit: 7, Vorstand: 10, Shareholderrechte: 8, Kompensation: 9.